Serum-Soluble ST2 Is a Novel Biomarker for Evaluating Left Atrial Low-Voltage Zone in Paroxysmal Atrial Fibrillation

BACKGROUND: Paroxysmal atrial fibrillation (pAF) recurrence after radiofrequency catheter ablation (RFCA) is linked to low-voltage zone (LVZ). This study explored whether serum soluble ST2 (sST2) levels can predict the size of LVZs in patients with pAF. MATERIAL/METHODS: A total of 177 patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zefeng, Cheng, Liting, Zhang, Junmeng, Liang, Zhuo, Dong, Ruiqing, Hang, Fei, Wang, Xinlu, Wang, Ziyu, Wu, Yongquan, Du, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2020
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500126/
https://www.ncbi.nlm.nih.gov/pubmed/32898129
http://dx.doi.org/10.12659/MSM.926221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500126/
https://www.ncbi.nlm.nih.gov/pubmed/32898129
http://dx.doi.org/10.12659/MSM.926221

Ejemplares similares